Cytokinetics (CYTK.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec5

Cytokinetics' EVP and COO Sold Company Stocks

22:41

Dec2

Cellular Dynamics Director John T. Henderson Sells Common Stock

22:14

Robert Arthur Harrington, Cytokinetics Inc. director, sells company stocks

14:14

Nov23

KBC Group NV Significantly Reduced Holdings in Celadon

10:37

Nov22

Cytokinetics Announces Positive Data for Aficamten Clinical Trials

09:52

Nov19

Cytokinetics Director Lynne B. Parshall Sells Common Stock

23:58

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.936 M, Net Income -306.18 M, EPS -2.5518

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 66.77 M, Net Income -134.37 M, EPS -1.1248

May6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.579 M, Net Income -161.38 M, EPS -1.3618

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change